Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in…
News
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT…
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT…
Shockwave Medical Appoints Nick West as Associate Chief Medical Officer
Nick West, MD, joins Shockwave from Abbott Vascular SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE…
Shockwave Medical Appoints Nick West as Associate Chief Medical Officer
Nick West, MD, joins Shockwave from Abbott Vascular SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE…
LifeSci Partners Expands Presence in Asia Pacific with Appointment of Jeff Seo
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) — LifeSci Partners, the leading provider of strategic…
LifeSci Partners Expands Presence in Asia Pacific with Appointment of Jeff Seo
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) — LifeSci Partners, the leading provider of strategic…
Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial
Fort Lee, NJ, Sept. 12, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis”…
Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial
Fort Lee, NJ, Sept. 12, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis”…
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Sensorium Therapeutics (Sensorium), a biotechnology company translating insights…
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Sensorium Therapeutics (Sensorium), a biotechnology company translating insights…
Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG,…
Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG,…
Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity
MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), a leading fully integrated…
Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity
MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), a leading fully integrated…
Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer
CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the…
Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer
CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the…
Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight
Top-line 48-week results from the trial expected Q4 2023 GAITHERSBURG, Md., Sept. 12, 2023 (GLOBE…